Clinical Trial Update: Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating a combination of sirolimus, abatacept, and mycophenolate mofetil to prevent aGraft-versus-Host Disease in haploidentical H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Abatacept (abatacept)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Sirolimus (Sirolimus)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: UNKNOWN